Pay in 4 interest-free payments of $5.72 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
These amounts are too low to be considered therapeutic and are not included in any clinical guidelines
95% CI, 4.174 to 0.216
Diabetes 63:24862497 Nauck MA, Petrie JR, Sesti G et al (2016) A phase 2, randomized, dose-finding study of the novel once-weekly human GLP-1 analog, semaglutide, compared with placebo and open-label liraglutide in patients with type 2 diabetes
Contact for further information Media: Liz Skrbkova (US) +1 609 917 0632 (Mobile) [email protected] Jamie Bennett (US) +1 640 250 1881 (Mobile) [email protected] References Ozempic (semaglutide) injection [package insert]
La probabilidad de revertir la diabetes por SEMA 2,4mg se mostr claramente superior a placebo en el estudio STEP1017 (tabla 1)
US$ 20.44
US$ 21.95
US$ 20.86
US$ 24.77
